| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.11% | 75.23% | 70.41% | 74.13% | 61.68% | 71.37% | 64.75% | 62.51% | 67.24% | 58.93% | 70.49% | 74.04% |
| Operating Margin | 11.23% | 16.60% | -2.65% | -53.47% | -108.70% | -621.14% | -542.56% | -388.11% | -517.85% | -241.01% | -459.63% | -703.77% |
| EBITDA Margin | 13.44% | 20.11% | 2.39% | -47.78% | -104.61% | -613.78% | -537.91% | -386.90% | -514.59% | -239.57% | -459.26% | -702.08% |
| Net Margin | 26.82% | -96.13% | -126.52% | -61.48% | -209.52% | -762.56% | -649.55% | -628.70% | -749.86% | -467.93% | -498.22% | -705.02% |
| Current Ratio | 1.38 | 0.43 | 0.15 | 0.11 | 0.08 | 0.22 | 0.20 | 0.07 | 0.11 | 0.12 | 0.43 | 0.65 |
| Quick Ratio | 1.05 | 0.34 | 0.11 | 0.10 | 0.06 | 0.14 | 0.16 | 0.04 | 0.09 | 0.09 | 0.24 | 0.61 |
| Debt / Equity | 13.52 | — | — | -0.04 | -0.67 | -1.22 | -0.06 | -0.12 | 0.00 | -0.78 | — | — |
| ROE | 729.65% | 246.69% | 59.77% | 25.10% | 69.97% | 225.51% | 103.83% | 75.74% | 56.74% | 93.16% | 81.84% | 385.08% |
| ROA | 31.63% | -104.16% | -115.13% | -51.79% | -146.40% | -134.35% | -293.61% | -987.61% | -433.05% | -640.78% | -501.93% | -128.02% |
| Asset Turnover | 1.18 | 1.08 | 0.91 | 0.84 | 0.70 | 0.18 | 0.45 | 1.57 | 0.58 | 1.37 | 1.01 | 0.18 |
| Book Value / Share | 0.18 | -2.85 | -0.05 | -0.07 | -0.08 | -0.04 | -0.05 | -0.10 | -0.07 | -0.06 | -0.09 | -0.03 |
Sanuwave Health Inc. is an innovative company within the medical technology sector, focusing primarily on the development and commercialization of non-invasive, shockwave-based devices for a variety of medical conditions. The company's flagship products are designed to promote healing in soft tissue and bone through its proprietary, high-energy, and low-energy pressure waves. These devices find applications in wound healing, particularly in chronic and diabetic ulcers, as well as in orthopedic conditions, broadening their reach across healthcare markets. Sanuwave Health Inc.'s technologies hold significance for improving patient outcomes, reducing healing times, and minimizing the need for more invasive procedures. Headquartered in Alpharetta, Georgia, the company continues to impact the medical industry by driving advancements in regenerative medicine solutions through its innovative approaches.